Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Internal Medicine (Tokyo, Japan)|July 16, 2005
Infective endocarditis developing as uremiaMakoto Miyake, Kazuhiro Hatta, Takayuki Kameyama, et al.
The Annals of Thoracic Surgery|January 17, 2004
Visualization of intramuscular left anterior descending coronary arteries during off-pump bypass surgerySenri Miwa, Takeshi Nishina, Koji Ueyama, et al.
Bioscience, Biotechnology, and Biochemistry|July 5, 2003
Production and characterization of biosurfactants from Bacillus licheniformis F2.2Jiraporn Thaniyavarn, Niran Roongsawang, Takayuki Kameyama, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 30, 2004
Hypoxic pulmonary vasoconstriction disappears in a rabbit model of cavopulmonary shuntAkio Ikai, Mikiyasu Shirai, Kazunobu Nishimura, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 6, 2005
Maintenance of pulmonary vasculature tone by blood derived from the inferior vena cava in a rabbit model of cavopulmonary shuntAkio Ikai, Mikiyasu Shirai, Kazunobu Nishimura, et al.
Extremophiles : Life Under Extreme Conditions|December 18, 2002
Isolation and characterization of a halotolerant Bacillus subtilis BBK-1 which produces three kinds of lipopeptides: bacillomycin L, plipastatin, and surfactinNiran Roongsawang, Jiraporn Thaniyavarn, Suthep Thaniyavarn, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2018
Pyrrolinone derivatives as a new class of P2X3 receptor antagonists. Part 1: Initial structure-activity relationship studies of a hit from a high throughput screeningHiroyuki Tobinaga, Takayuki Kameyama, Miho Oohara, et al.
Bioorganic & Medicinal Chemistry Letters|February 4, 2021
Dioxotriazine derivatives as a new class of P2X<sub>3</sub> receptor antagonists: Identification of a lead and initial SAR studiesHiroyuki Kai, Tohru Horiguchi, Takayuki Kameyama, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2019
Pyrrolinone derivatives as a new class of P2X3 receptor antagonists Part 2: Discovery of orally bioavailable compoundsHiroyuki Tobinaga, Takayuki Kameyama, Kentarou Asahi, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2020
Pyrrolinone derivatives as a new class of P2X3 receptor antagonists. Part 3: Structure-activity relationships of pyrropyrazolone derivativesHiroyuki Tobinaga, Takayuki Kameyama, Kentarou Asahi, et al.
Pageof 1